Entering text into the input field will update the search result below

Baxter inks deal for trace elements for PN therapy

Apr. 02, 2015 10:22 AM ETBaxter International Inc. (BAX) StockBAXBy: Douglas W. House, SA News Editor
  • Baxter International (BAX +0.5%) and Lyon, France-based Laboratoire Aguettant SAA ink an exclusive license and distribution agreement for trace elements, essential micronutrients used in parenteral nutrition (PN) therapy. The agreement will allow Baxter to augment its PN portfolio with essential trace elements, including NUTRYELT concentrate solution (multi-trace element product) and SELENIUM and ZINC (single-trace element products). Financial terms are not disclosed.
  • Parenteral (intravenous) nutrition is a therapy for patients who cannot ingest food orally or via an enteral tube.

Recommended For You

More Trending News

About BAX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
BAX--
Baxter International Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.